In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing for a healthcare partner in Puerto Rico. By the end of November, CTS implements universal individual Zika testing on all blood donations in the US, due to an FDA requirement.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...